A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.
about
Promise of personalized omics to precision medicineFrom integrative genomics to therapeutic targetsIntegrated analysis of transcriptomic and proteomic dataCharacterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.Systems biology: personalized medicine for the future?Onco-STS: a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.DAPK3 suppresses acini morphogenesis and is required for mouse development.Personal genomes, quantitative dynamic omics and personalized medicineThe clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.The tandem duplicator phenotype as a distinct genomic configuration in cancerPhysiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycleThree-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelPrecision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast CancerGermline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development.miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer.Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus.Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas.
P2860
Q26852592-EAF74D9E-5E4D-462F-82ED-9EBD81198F4FQ26862726-391EE292-194A-49BC-97BD-AE2A385A81DCQ28707991-FA453D03-8554-437A-8DAD-9C251E605DA7Q33579776-E7ADF745-270E-44CF-942F-137E993765F1Q33824947-2B5E60A2-E034-4FAC-A74A-7737705F36A4Q34887923-2AFB4FA9-8945-4C03-A045-D97CA946E8BBQ35108916-470960A5-E688-4512-977D-9238F6C3EC17Q35195408-919ED048-CD53-4D86-98E8-9CA7B7C8A983Q35666862-DCB84BEA-5222-40F1-AE71-6DAAAF1E56FEQ36833424-5D188EC5-F8D0-4B70-B96D-E780EECED37CQ36866171-FB43B22B-1005-47F6-8363-F8AD943717BCQ37271818-AECFAC5A-AED4-4BD1-A4A7-06650F5AB7E9Q37371138-17F876EA-F953-49B0-8829-48FE87B4A740Q38364614-B7BC2806-986B-4B75-9CBB-661003895A3BQ38921045-AE7D537D-81DE-47B4-835E-2B120A7D651DQ41139971-EB2A40ED-EBD6-48D2-A4DC-D15D9114737BQ41356138-10061F36-817C-4CF1-8F93-FD60060E1665Q41879406-1ACA360C-6F23-45E4-BCD2-0EED46957706Q41905883-FAD38754-BDFE-4683-BBFF-219AF71181E8Q41980556-35997083-1235-46D4-95B2-0BBA75C0C439Q42473382-7030D872-EFEF-4F14-90E7-BE8A0F1FDC53Q47095825-13B8B155-9667-4CEC-A47A-F6A4D878CD8AQ51102156-3AAF57CA-5C08-4B29-922D-A3A704DDE6FBQ54249734-918EDF9C-49EB-4788-90D3-C4F5FDD05169
P2860
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A whole-genome massively paral ...... and -positive breast cancers.
@en
A whole-genome massively paral ...... and -positive breast cancers.
@nl
type
label
A whole-genome massively paral ...... and -positive breast cancers.
@en
A whole-genome massively paral ...... and -positive breast cancers.
@nl
prefLabel
A whole-genome massively paral ...... and -positive breast cancers.
@en
A whole-genome massively paral ...... and -positive breast cancers.
@nl
P2093
P2860
P50
P356
P1476
A whole-genome massively paral ...... and -positive breast cancers.
@en
P2093
Adriana C Flora
Alan Mackay
Daniel-Nava Rodruigues
Elodie Manie
Iwanka Kozarewa
Jason Carroll
Marc Henri Stern
Maryou B Lambros
Odette Mariani
P2860
P356
10.1002/PATH.4003
P50
P577
2012-02-23T00:00:00Z